Related Experiment Videos

The erbB-3 gene in human pancreatic cancer

N R Lemoine1, M Lobresco, H Leung

  • 1Molecular Pathology Laboratory, Hammersmith Hospital, London, U.K.

The Journal of Pathology
|November 1, 1992
PubMed

Insights

Overexpression of the erbB-3 protein is frequent in pancreatic cancer and chronic pancreatitis. This suggests erbB-3 may play a role in pancreatic diseases, though its gene shows no amplification or rearrangement.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • The type 1 growth factor receptor family is implicated in pancreatic cancer pathogenesis.
  • Overexpression of epidermal growth factor (EGF) receptor, its ligands, and erbB-2 suggests an autocrine loop.
  • erbB-3, a newly recognized member, shows abnormal expression in various human cancers.

Purpose of the Study:

  • To investigate the expression and genetic status of erbB-3 in pancreatic cancer and chronic pancreatitis.
  • To determine if erbB-3 overexpression is a frequent event in these conditions.

Main Methods:

  • Protein expression analysis of erbB-3 in pancreatic tissues.
  • Southern blot analysis of erbB-3 gene in pancreatic cancer cell lines to detect amplification or rearrangement.

Main Results:

  • Overexpression of the erbB-3 protein was observed very frequently in carcinoma of the exocrine pancreas.
  • Elevated erbB-3 protein levels were also found in chronic pancreatitis.
  • No evidence of erbB-3 gene amplification or rearrangement was detected in pancreatic cancer cell lines.

Conclusions:

  • erbB-3 protein overexpression is a common finding in both pancreatic cancer and chronic pancreatitis.
  • The study suggests a potential role for erbB-3 in the pathogenesis of these pancreatic conditions.
  • Genetic alterations (amplification/rearrangement) of the erbB-3 gene do not appear to drive its overexpression in pancreatic cancer.

Related Concept Videos